Global Health Progress Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases
Released on: February 25, 2011, 05:54 am
Author:
Mark Grayson/ Global Health Progress
Industry:
Pharmaceuticals
The third-annual Global Funding of Innovation for Neglected
Diseases (G-FINDER) survey was released last week revealing both good
and bad news for the funding of neglected diseases in the developing
world. In a press release issued by Policy Cures, an independent group
providing research and analysis for those involved in the creation of
new pharmaceuticals for neglected diseases, the group reveals that
while funding for neglected diseases has increased, funding for new
products has decreased. Funders appear to be focusing more of their
money toward traditional basic research. This shift has caused a $50
million drop in funding for Product Development Partnerships (PDP),
non-profit organizations that partner with external organizations to
drive product development for neglected diseases, including neglected
tropical diseases.
Report author Dr Mary Moran, Director of Policy Cures warns funders not to “take
their eyes off the ball” in the press release, stating that while the increase in
funding is encouraging it is important that the funds are spent wisely.
Global Health Progress has worked with partner groups to encourage and sustain
funding for the research and development of new products. The innovative research
and development (R&D) of new drugs and vaccines is a critical component of improving
health care and combating epidemics of neglected tropical diseases in developing
countries. There are no vaccines or cures for some widespread and life threatening
diseases such as malaria, while existing treatments for diseases such as
tuberculosis are becoming less effective due to drug resistance.
Read the full press release from Policy Cures here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/G-FINDER_Year_3_media_release.pdf,
or read the G-FINDER report on the Policy Cures website:
http://www.policycures.org/downloads/g-finder_2010.pdf.
About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize
resources to address health challenges in the developing world by bringing local
leaders together with international health experts, policymakers, donor governments,
and the private sector. www.globalhealthprogress.org; twitter.com/globalhealth;
facebook.com/pages/Global-Health-Progress/124850684219049;
linkedin.com/groups?home=&gid=2972068
To stay informed on the latest news about global investment in pharmaceutical R&D
and improving access to medicines, sign up to receive special alerts and
newsletters. You can also spread the word about the efforts of the Global Health
Progress initiative and keep others informed about how we're affecting change
around the world or share your story about how you or someone you know is working to
promote global health.
Contact Details: Mark Grayson
Global Health Progress
950 F Street, NW
Suite 300
Washington, DC 20004
202.835.3400
202.835.3414
MGrayson@phrma.org
http://globalhealthprogress.org
Back to previous page
Home page
Submit your press release
2025
